US equities
|
NVDA
$152.54
▼-1.88%
MU
$696.11
▼-2.29%
AMD
$507.89
▲+0.89%
SPCX
$144.33
▲+1.86%
SNDK
$762.99
▼-4.30%
AAPL
$353.07
▲+0.33%
TSLA
$380.34
▲+0.06%
AMZN
$263.69
▲+2.25%
NVDA
$152.54
▼-1.88%
MU
$696.11
▼-2.29%
AMD
$507.89
▲+0.89%
SPCX
$144.33
▲+1.86%
SNDK
$762.99
▼-4.30%
AAPL
$353.07
▲+0.33%
TSLA
$380.34
▲+0.06%
AMZN
$263.69
▲+2.25%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Dr/ Rob Conley
Recent news which mentions Dr/ Rob Conley
Beckley Psytech Begins Phase IIa Study Of Psychedelic Compound To Treat Depression
May 04, 2023
Tags
General
Psychedelics
Market News
From
Benzinga